Ruth Etzioni - Publications

University of Washington, Seattle, Seattle, WA 
Health Care Management, Epidemiology

160 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. The Lancet. Global Health. 6: e885-e893. PMID 30012269 DOI: 10.1016/S2214-109X(18)30257-2  0.36
2017 Verdial FC, Etzioni R, Duggan C, Anderson BO. Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening. Journal of Surgical Oncology. PMID 28194807 DOI: 10.1002/jso.24579  0.36
2016 Gulati R, Etzioni R. A Matched Cohort Analysis of Prostate Cancer Screening in Younger Men in Sweden. European Urology. PMID 27090976 DOI: 10.1016/j.eururo.2016.04.006  0.32
2016 Birnbaum J, Gadi VK, Markowitz E, Etzioni R. The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model. Annals of Internal Medicine. PMID 26756332 DOI: 10.7326/M15-0754  0.32
2016 Etzioni R, Gulati R. Active Surveillance for Ductal Carcinoma in Situ: Shining Light Into the Modeling Abyss. Journal of the National Cancer Institute. 108. PMID 26683406 DOI: 10.1093/jnci/djv378  0.32
2016 Etzioni R, Gulati R. Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them. Journal of the National Cancer Institute. 108. PMID 26582245 DOI: 10.1093/jnci/djv345  0.32
2015 Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. Jama. 314: 1599-614. PMID 26501536 DOI: 10.1001/jama.2015.12783  0.32
2015 Birnbaum JK, Ademuyiwa FO, Carlson JJ, Mallinger L, Mason MW, Etzioni R. Comparative Effectiveness of Biomarkers to Target Cancer Treatment: Modeling Implications for Survival and Costs. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 26304062 DOI: 10.1177/0272989X15601998  0.36
2015 Elmore JG, Etzioni R. Effect of Screening Mammography on Cancer Incidence and Mortality. Jama Internal Medicine. 175: 1490-1. PMID 26147329 DOI: 10.1001/jamainternmed.2015.3056  0.32
2015 Loggers ET, Gao H, Gold LS, Kessler L, Etzioni R, Buist DS. Predictors of preoperative MRI for breast cancer: differences by data source. Journal of Comparative Effectiveness Research. 1-12. PMID 25960128 DOI: 10.2217/cer.15.1  0.32
2015 Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Etzioni R, Porter CR. Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer. 121: 2465-73. PMID 25845467 DOI: 10.1002/cncr.29370  0.32
2015 Habbema JD, Wilt TJ, Etzioni R. Models in the development of clinical practice guidelines. Annals of Internal Medicine. 162: 530-1. PMID 25845011 DOI: 10.7326/L15-5075-2  0.32
2015 Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator. European Urology. 68: 1083-8. PMID 25819722 DOI: 10.1016/j.eururo.2015.03.023  0.32
2015 Etzioni R, Gulati R, Lin DW. Measures of survival benefit in cancer drug development and their limitations. Urologic Oncology. 33: 122-7. PMID 25813143 DOI: 10.1016/j.urolonc.2014.11.002  0.32
2015 Birnbaum JK, Feng Z, Gulati R, Fan J, Lotan Y, Wei JT, Etzioni R. Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 677-82. PMID 25613117 DOI: 10.1158/1055-9965.EPI-14-1224  0.32
2015 Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. Tumor marker usage and medical care costs among older early-stage breast cancer survivors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 149-55. PMID 25332254 DOI: 10.1200/JCO.2014.55.5409  0.32
2015 Weiner AB, Patel SG, Etzioni R, Eggener SE. National Trends in the Management of Low and Intermediate Risk Prostate Cancer in the United States Journal of Urology. DOI: 10.1016/j.juro.2014.07.111  0.32
2014 Habbema JD, Wilt TJ, Etzioni R, Nelson HD, Schechter CB, Lawrence WF, Melnikow J, Kuntz KM, Owens DK, Feuer EJ. Models in the development of clinical practice guidelines. Annals of Internal Medicine. 161: 812-8. PMID 25437409 DOI: 10.7326/M14-0845  0.32
2014 Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R. A reality check for overdiagnosis estimates associated with breast cancer screening. Journal of the National Cancer Institute. 106. PMID 25362701 DOI: 10.1093/jnci/dju315  0.32
2014 Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5302-10. PMID 25320374 DOI: 10.1158/1078-0432.CCR-13-3366  0.32
2014 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, et al. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1211-9; quiz 1219. PMID 25190691  0.32
2014 Gulati R, Tsodikov A, Etzioni R, Hunter-Merrill RA, Gore JL, Mariotto AB, Cooperberg MR. Expected population impacts of discontinued prostate-specific antigen screening. Cancer. 120: 3519-26. PMID 25065910 DOI: 10.1002/cncr.28932  0.32
2014 Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Annals of Internal Medicine. 161: 104-12. PMID 25023249 DOI: 10.7326/M13-2867  0.32
2014 Etzioni R, Gulati R. Oversimplifying overdiagnosis. Journal of General Internal Medicine. 29: 1218-20. PMID 24830739 DOI: 10.1007/s11606-014-2867-0  0.32
2014 Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Annals of Internal Medicine. 160: 594-602. PMID 24798522 DOI: 10.7326/M13-2348  0.32
2014 Etzioni RD, Thompson IM. What do the screening trials really tell us and where do we go from here? The Urologic Clinics of North America. 41: 223-8. PMID 24725484 DOI: 10.1016/j.ucl.2014.01.002  0.32
2014 Etzioni R, Gulati R. RE: A model too far. Journal of the National Cancer Institute. 106: dju058. PMID 24659791 DOI: 10.1093/jnci/dju058  0.32
2014 Weiner AB, Etzioni R, Eggener SE. Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance. European Urology. 66: 611-2. PMID 24630416 DOI: 10.1016/j.eururo.2014.02.051  0.32
2014 Unger JM, Barlow WE, Martin DP, Ramsey SD, Leblanc M, Etzioni R, Hershman DL. Comparison of survival outcomes among cancer patients treated in and out of clinical trials. Journal of the National Cancer Institute. 106: dju002. PMID 24627276 DOI: 10.1093/jnci/dju002  0.32
2014 Etzioni R. Impact of prostate-specific antigen screening: building confidence. European Urology. 66: 404-5. PMID 24576500 DOI: 10.1016/j.eururo.2014.02.005  0.32
2014 Pataky R, Gulati R, Etzioni R, Black P, Chi KN, Coldman AJ, Pickles T, Tyldesley S, Peacock S. Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. International Journal of Cancer. Journal International Du Cancer. 135: 939-47. PMID 24443367 DOI: 10.1002/ijc.28732  0.32
2014 Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Overdiagnosis and overtreatment of prostate cancer. European Urology. 65: 1046-55. PMID 24439788 DOI: 10.1016/j.eururo.2013.12.062  0.32
2014 Gulati R, Inoue LY, Gore JL, Katcher J, Etzioni R. Individualized estimates of overdiagnosis in screen-detected prostate cancer. Journal of the National Cancer Institute. 106: djt367. PMID 24399850 DOI: 10.1093/jnci/djt367  0.32
2014 Inoue LY, Trock BJ, Partin AW, Carter HB, Etzioni R. Modeling grade progression in an active surveillance study. Statistics in Medicine. 33: 930-9. PMID 24123208 DOI: 10.1002/sim.6003  0.32
2013 Etzioni R, Durand-Zaleski I, Lansdorp-Vogelaar I. Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality. Journal of the National Cancer Institute. Monographs. 2013: 117-23. PMID 23962515 DOI: 10.1093/jncimonographs/lgt010  0.32
2013 Gold LS, Buist DS, Loggers ET, Etzioni R, Kessler L, Ramsey SD, Sullivan SD. Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. Journal of Oncology Practice / American Society of Clinical Oncology. 9: e194-202. PMID 23943885 DOI: 10.1200/JOP.2012.000796  0.32
2013 Schenk JM, Hunter-Merrill R, Zheng Y, Etzioni R, Gulati R, Tangen C, Thompson IM, Kristal AR. Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia? American Journal of Epidemiology. 178: 741-51. PMID 23813705 DOI: 10.1093/aje/kwt044  0.32
2013 Etzioni R, Gulati R, Mallinger L, Mandelblatt J. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Annals of Internal Medicine. 158: 831-8. PMID 23732716 DOI: 10.7326/0003-4819-158-11-201306040-00008  0.32
2013 Gulati R, Etzioni R. Alternative prostate cancer screening strategies--in response. Annals of Internal Medicine. 158: 778-9. PMID 23689774 DOI: 10.7326/0003-4819-158-10-201305210-00020  0.32
2013 Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL. Early detection of prostate cancer: AUA Guideline. The Journal of Urology. 190: 419-26. PMID 23659877 DOI: 10.1016/j.juro.2013.04.119  0.32
2013 Etzioni R, Gulati R. Response: Reading between the lines of cancer screening trials: using modeling to understand the evidence. Medical Care. 51: 304-6. PMID 23481032 DOI: 10.1097/MLR.0b013e31828a7e1a  0.32
2013 Ayala G, Frolov A, Ittman M, Mohammed S, LeBlanc M, Falcon S, Rowley D, Etzioni R. Biological correlates of biochemical recurrence free survival using multiple markers in a large tissue microarray cohort. Annals of Clinical and Laboratory Science. 43: 11-21. PMID 23462601  0.32
2013 Xia J, Gulati R, Au M, Gore JL, Lin DW, Etzioni R. Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial. Journal of the National Cancer Institute. 105: 546-50. PMID 23411592 DOI: 10.1093/jnci/djt017  0.32
2013 Gulati R, Gore JL, Etzioni R. Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms. Annals of Internal Medicine. 158: 145-53. PMID 23381039 DOI: 10.7326/0003-4819-158-3-201302050-00003  0.32
2013 Wender R, Fontham ET, Barrera E, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, et al. American Cancer Society lung cancer screening guidelines. Ca: a Cancer Journal For Clinicians. 63: 107-17. PMID 23315954 DOI: 10.3322/caac.21172  0.32
2013 Etzioni R, Gulati R, Cooperberg MR, Penson DM, Weiss NS, Thompson IM. Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Medical Care. 51: 295-300. PMID 23269114 DOI: 10.1097/MLR.0b013e31827da979  0.32
2013 Etzioni RD. Review of evidence concerning PSA screening for prostate cancer has limitations as basis for policy development. Evidence-Based Medicine. 18: 75-6. PMID 22773765 DOI: 10.1136/eb-2012-100803  0.32
2013 Inoue LYT, Gulati R, Yu C, Kattan MW, Etzioni R. Deriving benefit of early detection from biomarker-based prognostic models Biostatistics. 14: 15-27. PMID 22730510 DOI: 10.1093/biostatistics/kxs018  0.32
2012 Mandelblatt J, Schechter C, Levy D, Zauber A, Chang Y, Etzioni R. Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 32: 656-9. PMID 22990079 DOI: 10.1177/0272989X12458978  0.32
2012 Etzioni R, Mucci L, Chen S, Johansson JE, Fall K, Adami HO. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6742-7. PMID 22927485 DOI: 10.1158/1078-0432.CCR-12-1537  0.32
2012 Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EA, Katcher J, Draisma G, Feuer EJ, de Koning HJ, Mariotto AB. The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer. 118: 5955-63. PMID 22605665 DOI: 10.1002/cncr.27594  0.32
2012 Gulati R, Tsodikov A, Wever EM, Mariotto AB, Heijnsdijk EA, Katcher J, de Koning HJ, Etzioni R. The impact of PLCO control arm contamination on perceived PSA screening efficacy. Cancer Causes & Control : Ccc. 23: 827-35. PMID 22488488 DOI: 10.1007/s10552-012-9951-8  0.32
2012 Rubinsky AD, Sun H, Blough DK, Maynard C, Bryson CL, Harris AH, Hawkins EJ, Beste LA, Henderson WG, Hawn MT, Hughes G, Bishop MJ, Etzioni R, Tønnesen H, Kivlahan DR, et al. AUDIT-C alcohol screening results and postoperative inpatient health care use. Journal of the American College of Surgeons. 214: 296-305.e1. PMID 22244208 DOI: 10.1016/j.jamcollsurg.2011.11.007  0.32
2012 Zeliadt SB, Buist DS, Reid RJ, Grossman DC, Ma J, Etzioni R. Biopsy follow-up of prostate-specific antigen tests. American Journal of Preventive Medicine. 42: 37-43. PMID 22176844 DOI: 10.1016/j.amepre.2011.08.024  0.32
2011 Gulati R, Mariotto AB, Chen S, Gore JL, Etzioni R. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. Journal of Clinical Epidemiology. 64: 1412-7. PMID 22032753 DOI: 10.1016/j.jclinepi.2011.06.011  0.32
2011 Gulati R, Wever EM, Tsodikov A, Penson DF, Inoue LY, Katcher J, Lee SY, Heijnsdijk EA, Draisma G, de Koning HJ, Etzioni R. What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 740-50. PMID 21546365 DOI: 10.1158/1055-9965.EPI-10-0718  0.32
2011 Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. Journal of the National Cancer Institute. 103: 520-3. PMID 21357307 DOI: 10.1093/jnci/djr007  0.32
2011 Ramsey SD, Etzioni R. Case-control studies of cancer surveillance procedures. Journal of Clinical Epidemiology. 64: 44. PMID 21130351 DOI: 10.1016/j.jclinepi.2010.07.011  0.32
2011 Williams LH, Miller DR, Fincke G, Lafrance JP, Etzioni R, Maynard C, Raugi GJ, Reiber GE. Depression and incident lower limb amputations in veterans with diabetes. Journal of Diabetes and Its Complications. 25: 175-82. PMID 20801060 DOI: 10.1016/j.jdiacomp.2010.07.002  0.32
2010 Fedewa SA, Etzioni R, Flanders WD, Jemal A, Ward EM. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2437-44. PMID 20705937 DOI: 10.1158/1055-9965.EPI-10-0299  0.32
2010 Zeliadt SB, Hoffman RM, Etzioni R, Ginger VA, Lin DW. What happens after an elevated PSA test: the experience of 13,591 veterans. Journal of General Internal Medicine. 25: 1205-10. PMID 20697965 DOI: 10.1007/s11606-010-1468-9  0.32
2010 Gulati R, Inoue L, Katcher J, Hazelton W, Etzioni R. Calibrating disease progression models using population data: a critical precursor to policy development in cancer control. Biostatistics (Oxford, England). 11: 707-19. PMID 20530126 DOI: 10.1093/biostatistics/kxq036  0.32
2010 Yu EY, Gulati R, Telesca D, Jiang P, Tam S, Russell KJ, Nelson PS, Etzioni RD, Higano CS. Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2668-73. PMID 20421544 DOI: 10.1200/JCO.2009.25.1330  0.32
2010 Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA. American Cancer Society guideline for the early detection of prostate cancer: update 2010. Ca: a Cancer Journal For Clinicians. 60: 70-98. PMID 20200110 DOI: 10.3322/caac.20066  0.32
2010 Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 240-62. PMID 20141680  0.32
2009 Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. Journal of the National Cancer Institute. 101: 374-83. PMID 19276453 DOI: 10.1093/jnci/djp001  0.32
2009 Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 808-15. PMID 19258479 DOI: 10.1158/1055-9965.EPI-08-0784  0.32
2009 Telesca D, Inoue LY, Neira M, Etzioni R, Gleave M, Nelson C. Differential expression and network inferences through functional data modeling. Biometrics. 65: 793-804. PMID 19053995 DOI: 10.1111/j.1541-0420.2008.01159.x  0.32
2009 Etzioni R, Kessler L, Di Tommaso D. Using Public Health Data to Evaluate Screening Programs: Application to Prostate Cancer Monitoring the Health of Populations : Statistical Principles and Methods For Public Health Surveillance. DOI: 10.1093/acprof:oso/9780195146493.003.0006  0.32
2009 Etzioni R. Editorial Comment Journal of Urology. 181: 1613. DOI: 10.1016/j.juro.2008.11.166  0.32
2008 Inoue LY, Etzioni R, Morrell C, Müller P. Modeling Disease Progression with Longitudinal Markers. Journal of the American Statistical Association. 103: 259-270. PMID 24453387 DOI: 10.1198/016214507000000356  0.32
2008 Thompson IM, Ankerst DP, Etzioni R, Wang T. It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer. The Journal of Urology. 180: 1219-22. PMID 18707707 DOI: 10.1016/j.juro.2008.07.089  0.32
2008 Etzioni R, Feuer E. Studies of prostate-cancer mortality: caution advised. The Lancet. Oncology. 9: 407-9. PMID 18452850 DOI: 10.1016/S1470-2045(08)70112-8  0.32
2008 Etzioni R. Statistical issues in the evaluation of screening and early detection modalities. Urologic Oncology. 26: 308-15. PMID 18452826 DOI: 10.1016/j.urolonc.2006.11.008  0.32
2008 Etzioni R, Gulati R, Falcon S, Penson DF. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 28: 323-31. PMID 18319508 DOI: 10.1177/0272989X07312719  0.32
2008 Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes & Control : Ccc. 19: 175-81. PMID 18027095 DOI: 10.1007/s10552-007-9083-8  0.32
2008 Telesca D, Etzioni R, Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics. 64: 10-9. PMID 17501937 DOI: 10.1111/j.1541-0420.2007.00825.x  0.32
2007 Etzioni RD, Ankerst DP, Weiss NS, Inoue LY, Thompson IM. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. Journal of the National Cancer Institute. 99: 1510-5. PMID 17925534 DOI: 10.1093/jnci/djm171  0.32
2007 Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, et al. Prostate cancer early detection. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 714-36. PMID 17692177  0.32
2007 Ramsey SD, Howlader N, Etzioni R, Brown ML, Warren JL, Newcomb P. Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer. 109: 2222-8. PMID 17410533 DOI: 10.1002/cncr.22673  0.32
2007 Etzioni RD, Ankerst DP, Thompson IM. Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. Journal of the National Cancer Institute. 99: 489-90; author reply. PMID 17374841 DOI: 10.1093/jnci/djk100  0.32
2007 Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer. 109: 1877-86. PMID 17372918 DOI: 10.1002/cncr.22607  0.32
2007 Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Medical Care. 45: 154-9. PMID 17224778 DOI: 10.1097/01.mlr.0000241044.09778.3f  0.32
2007 Inoue LY, Neira M, Nelson C, Gleave M, Etzioni R. Cluster-based network model for time-course gene expression data. Biostatistics (Oxford, England). 8: 507-25. PMID 16980695 DOI: 10.1093/biostatistics/kxl026  0.32
2007 Etzioni D, Howlader N, Etzioni R. Basic statistical methods Clinical Research Methods For Surgeons. 123-139. DOI: 10.1007/978-1-59745-230-4_8  0.32
2006 DeConde RP, Hawley S, Falcon S, Clegg N, Knudsen B, Etzioni R. Combining results of microarray experiments: a rank aggregation approach. Statistical Applications in Genetics and Molecular Biology. 5: Article15. PMID 17049026 DOI: 10.2202/1544-6115.1204  0.32
2006 Zeliadt SB, Potosky AL, Penson DF, Etzioni R. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 66: 395-402. PMID 16904843 DOI: 10.1016/j.ijrobp.2006.04.048  0.32
2006 Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer. 106: 320-8. PMID 16342294 DOI: 10.1002/cncr.21603  0.32
2006 Pinsky P, Etzioni R, Howlader N, Goodman P, Thompson IM. Modeling the effect of a preventive intervention on the natural history of cancer: Application to the Prostate Cancer Prevention Trial International Journal of Biostatistics. 2.  0.32
2005 Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. The Journal of Urology. 174: 877-81. PMID 16093979 DOI: 10.1097/01.ju.0000169255.64518.fb  0.32
2005 Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. The American Journal of Medicine. 118: 850-7. PMID 16084177 DOI: 10.1016/j.amjmed.2005.03.001  0.32
2005 Zeliadt SB, Etzioni R, Kristal AR. Estimated impact of the prostate cancer prevention trial on population mortality. Cancer. 104: 1556-7; author reply. PMID 16015625 DOI: 10.1002/cncr.21344  0.32
2005 Etzioni R, Hawley S, Billheimer D, True LD, Knudsen B. Analyzing patterns of staining in immunohistochemical studies: application to a study of prostate cancer recurrence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1040-6. PMID 15894650 DOI: 10.1158/1055-9965.EPI-04-0584  0.32
2005 Friedrichsen DM, Hawley S, Shu J, Humphrey M, Sabacan L, Iwasaki L, Etzioni R, Ostrander EA, Stanford JL. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. The Prostate. 65: 44-51. PMID 15800934 DOI: 10.1002/pros.20259  0.32
2005 Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I, Nelson PS. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. International Journal of Cancer. Journal International Du Cancer. 114: 563-71. PMID 15609334 DOI: 10.1002/ijc.20773  0.32
2004 Ramsey SD, Howlader N, Etzioni RD, Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4971-8. PMID 15611512 DOI: 10.1200/JCO.2004.05.031  0.32
2004 Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 64: 1171-6. PMID 15596192 DOI: 10.1016/j.urology.2004.07.037  0.32
2004 Feuer EJ, Etzioni R, Cronin KA, Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Statistical Methods in Medical Research. 13: 421-42. PMID 15587432 DOI: 10.1191/0962280204sm376ra  0.32
2004 Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. American Journal of Epidemiology. 160: 1059-69. PMID 15561985 DOI: 10.1093/aje/kwh336  0.32
2004 Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Metastases of prostate cancer express estrogen receptor-beta. Urology. 64: 814-20. PMID 15491740 DOI: 10.1016/j.urology.2004.05.036  0.32
2004 Etzioni R, Thomas DB. Modelling the effect of screening for cervical cancer on the population. Lancet (London, England). 364: 224-6. PMID 15262081 DOI: 10.1016/S0140-6736(04)16687-7  0.32
2004 Weiss NS, Dhillon PK, Etzioni R. Case-control studies of the efficacy of cancer screening: overcoming bias from nonrandom patterns of screening. Epidemiology (Cambridge, Mass.). 15: 409-13. PMID 15232400 DOI: 10.1097/01.ede.0000129518.99816.e1  0.32
2004 Inoue LY, Etzioni R, Slate EH, Morrell C, Penson DF. Combining longitudinal studies of PSA. Biostatistics (Oxford, England). 5: 483-500. PMID 15208207 DOI: 10.1093/biostatistics/5.3.483  0.32
2004 Ramsey SD, Mandelson MT, Etzioni R, Harrison R, Smith R, Taplin S. Can administrative data identify incident cases of colorectal cancer? A comparison of two health plans Health Services and Outcomes Research Methodology. 5: 27-37. DOI: 10.1007/s10742-005-5562-0  0.32
2003 Ramsey SD, Mandelson MT, Berry K, Etzioni R, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology. 125: 1645-50. PMID 14724816 DOI: 10.1053/j.gastro.2003.09.032  0.32
2003 Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE. Endogenous Sex Hormones and Prostate Cancer Risk: A Case-Control Study Nested within the Carotene and Retinol Efficacy Trial Cancer Epidemiology Biomarkers and Prevention. 12: 1410-1416. PMID 14693730  0.32
2003 Etzioni R, Kooperberg C, Pepe M, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer Biostatistics (Oxford, England). 4: 523-538. PMID 14557109  0.32
2003 Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis Cancer. 98: 496-503. PMID 12879465 DOI: 10.1002/cncr.11492  0.32
2003 Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. The New England Journal of Medicine. 348: 2092-102. PMID 12759480 DOI: 10.1056/NEJMsa030448  0.32
2003 Lamharzi N, Johnson MM, Goodman G, Etzioni R, Weiss NS, Dightman DA, Barnett M, DiTommaso D, Chen C. Polymorphic markers in the 5α-reductase type II gene and the incidence of prostate cancer International Journal of Cancer. 105: 480-483. PMID 12712437 DOI: 10.1002/ijc.11126  0.32
2003 Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L. The case for early detection. Nature Reviews. Cancer. 3: 243-52. PMID 12671663 DOI: 10.1038/nrc1041  0.32
2002 Weiss NS, Etzioni R. Estimating the influence of rescreening interval on the benefits associated with cancer screening: Approaches and limitations Epidemiology. 13: 713-717. PMID 12410014 DOI: 10.1097/00001648-200211000-00017  0.32
2002 Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G. Androgen receptor polymorphisms and the incidence of prostate cancer Cancer Epidemiology Biomarkers and Prevention. 11: 1033-1040. PMID 12376504  0.32
2002 Kessler LG, Andersen MR, Etzioni R. Much ado mammography variability Journal of the National Cancer Institute. 94: 1346-1347. PMID 12237274 DOI: 10.1093/jnci/94.18.1346  0.32
2002 Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data Medical Care. 40. PMID 12187175  0.32
2002 Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. Journal of the National Cancer Institute. 94: 981-90. PMID 12096083  0.32
2002 Etzioni R, Riley GF, Ramsey SD, Brown M. Measuring costs: administrative claims data, clinical trials, and beyond Medical Care. 40. PMID 12064760  0.32
2002 Ramsey SD, Berry K, Etzioni R. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. The American Journal of Gastroenterology. 97: 440-5. PMID 11866285 DOI: 10.1111/j.1572-0241.2002.05483.x  0.32
2002 Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology. 59: 251-5. PMID 11834397 DOI: 10.1016/S0090-4295(01)01516-3  0.32
2002 Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N, Moeslein G. Microsatellite screening for hereditary nonpolyposis colorectal cancer is cost-effective Evidence-Based Healthcare. 6: 160. DOI: 10.1054/ebhc.2002.0561  0.32
2001 Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Annals of Internal Medicine. 135: 577-88. PMID 11601929  0.32
2001 Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute. 93: 1054-61. PMID 11459866  0.32
2001 Ellis WJ, Etzioni R, Vessella RL, Hu C, Goodman GE. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer Journal of Urology. 166: 93-98. PMID 11435831  0.32
2001 Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Economics. 10: 245-56. PMID 11288190 DOI: 10.1002/hec.580  0.32
2000 Ramsey SD, McIntosh M, Etzioni R, Urban N. Simulation modeling of outcomes and cost effectiveness Hematology/Oncology Clinics of North America. 14: 925-938. PMID 10949781  0.32
2000 Andersen MR, Yasui Y, Meischke H, Kuniyuki A, Etzioni R, Urban N. The effectiveness of mammography promotion by volunteers in rural communities American Journal of Preventive Medicine. 18: 199-207. PMID 10722985 DOI: 10.1016/S0749-3797(99)00161-0  0.32
2000 Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, Urban N. Quality of life in survivors of colorectal carcinoma Cancer. 88: 1294-1303. PMID 10717609 DOI: 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M  0.32
1999 Brown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease specific costs of care: Application to medicare enrollees diagnosed with colorectal cancer Medical Care. 37: 1249-1259. PMID 10599606 DOI: 10.1097/00005650-199912000-00008  0.32
1999 Feinstein LC, Seidel K, Jocum J, Bowden RA, Anasetti C, Deeg HJ, Flowers ME, Kansu E, Martin PJ, Nash RA, Storek J, Etzioni R, Applebaum FR, Hansen JA, Storb R, et al. Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 5: 369-78. PMID 10595814  0.32
1999 Etzioni RD, Feuer EJ, Sullivan SD, Lin D, Hu C, Ramsey SD. On the use of survival analysis techniques to estimate medical care costs. Journal of Health Economics. 18: 365-80. PMID 10537900 DOI: 10.1016/S0167-6296(98)00056-3  0.32
1999 Andersen MR, Urban N, Etzioni R. Community attitudes and mammography use: Does it really matter what other people think? Women and Health. 29: 83-95. PMID 10466512 DOI: 10.1300/J013v29n03_06  0.32
1999 Etzioni R, Cha R, Cowen ME. Serial prostate specific antigen screening for prostate cancer: A computer model evaluates competing strategies Journal of Urology. 162: 741-748. PMID 10458357 DOI: 10.1097/00005392-199909010-00032  0.32
1999 Etzioni R, Pepe M, Longton G, Hu C, Goodman G. Incorporating the time dimension in receiver operating characteristic curves: A case study of prostate cancer Medical Decision Making. 19: 242-251. PMID 10424831 DOI: 10.1177/0272989X9901900303  0.32
1999 Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. Journal of the National Cancer Institute. 91: 1033-9. PMID 10379966  0.32
1998 Cronin KA, Legler JM, Etzioni RD. Assessing uncertainty in microsimulation modelling with application to cancer screening interventions. Statistics in Medicine. 17: 2509-23. PMID 9819842 DOI: 10.1002/(SICI)1097-0258(19981115)17:21<2509::AID-SIM949>3.0.CO;2-V  0.32
1998 Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptornatic incidence and duration of prostate cancer American Journal of Epidemiology. 148: 775-785. PMID 9786232  0.32
1998 Etzioni RD, Weiss NS. Analysis of case-control studies of screening: Impact of misspecifying the duration of detectable preclinical pathologic changes American Journal of Epidemiology. 148: 292-297. PMID 9690367  0.32
1997 Ramsey SD, Etzioni R, Troxel A, Urban N. Optimizing sampling strategies for estimating quality-adjusted life years Medical Decision Making. 17: 431-438. PMID 9343801 DOI: 10.1177/0272989X9701700408  0.32
1997 Urban N, Drescher C, Etzioni R, Colby C. Use of stochastic stimulation model to identify an efficient protocol for ovarian cancer screening Controlled Clinical Trials. 18: 251-270. PMID 9204225 DOI: 10.1016/S0197-2456(96)00233-4  0.32
1997 Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data Biometrics. 53: 419-434. PMID 9192444 DOI: 10.2307/2533947  0.32
1997 Etzioni R, Shen Y. Estimating asymptomatic duration in cancer: The aids connection Statistics in Medicine. 16: 627-644. PMID 9131752 DOI: 10.1002/(SICI)1097-0258(19970330)16:6<627::AID-SIM438>3.0.CO;2-7  0.32
1996 Etzioni R, Shen Y, Petteway JC, Brawer MK. Age-specific prostate-specific antigen: A reassessment Prostate. 29: 70-77. PMID 8950367 DOI: 10.1002/(SICI)1097-0045(1996)7+<70::AID-PROS10>3.0.CO;2-O  0.32
1996 Crawford ED, DeAntoni EP, Etzioni R, Schaefer VC, Olson RM, Ross CA. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council. Urology. 47: 863-9. PMID 8677578 DOI: 10.1016/S0090-4295(96)00061-1  0.32
1996 Etzioni R, Urban N, Baker M. Estimating the costs attributable to a disease with application to ovarian cancer Journal of Clinical Epidemiology. 49: 95-103. PMID 8598518 DOI: 10.1016/0895-4356(96)89259-6  0.32
1996 Etzioni R, Thompson IM. Prostate cancer and computer models: Background, limitations, and potential Urologic Oncology. 2: 57-64. DOI: 10.1016/S1078-1439(96)00047-6  0.32
1995 Urban N, Taplin SH, Taylor VM, Peacock S, Anderson G, Conrad D, Etzioni R, White E, Montano DE, Mahloch J, Majer K. Community Organization to Promote Breast Cancer Screening among Women Ages 50-75 Preventive Medicine. 24: 477-484. PMID 8524722 DOI: 10.1006/pmed.1995.1076  0.32
1995 Self SG, Etzioni R. A likelihood ratio test for cancer screening trials Biometrics. 51: 44-50. PMID 7766795 DOI: 10.2307/2533313  0.32
1995 Etzioni R, Self SG. On the catch-up time method for analyzing cancer screening trials Biometrics. 51: 31-43. PMID 7766785 DOI: 10.2307/2533312  0.32
1995 Etzioni RD, Kadane JB. Bayesian statistical methods in public health and medicine Annual Review of Public Health. 16: 23-41. PMID 7639872  0.32
1995 Etzioni RD, Self SG, Connor RJ, Prorok PC. Design and analysis of cancer screening trials Statistical Methods in Medical Research. 4: 3-17. PMID 7613636 DOI: 10.1177/096228029500400102  0.32
1995 Anasetti C, Etzioni R, Petersdorf EW, Martin PJ, Hansen JA. Marrow transplantation from unrelated volunteer donors Annual Review of Medicine. 46: 169-179. PMID 7598453 DOI: 10.1146/  0.32
1995 Nash RA, Etzioni R, Storb R, Furlong T, Gooley T, Anasetti C, Appelbaum FR, Doney K, Martin P, Slattery J, Sullivan K, Van Der Jagt R, Witherspoon R, Jusko WJ, Zager RA, et al. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: A single-center study Blood. 85: 3746-3753. PMID 7540071  0.32
1994 Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 84: 941-9. PMID 8043876  0.32
1994 Etzioni RD, Fienberg SE, Gilula Z, Haberman SJ. Statistical models for the analysis of ordered categorical data in public health and medical research Statistical Methods in Medical Research. 3: 179-204. PMID 7952431  0.32
1994 Etzioni R, Pepe MS. Monitoring of a pilot toxicity study with two adverse outcomes Statistics in Medicine. 13: 2311-2321. PMID 7855465  0.32
1994 Mickelson EM, Guthrie LA, Etzioni R, Anasetti C, Martin PJ, Hansen JA. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: Matching for transplants from related haploidentical donors Tissue Antigens. 44: 83-92. PMID 7817382  0.32
1994 Etzioni O, Etzioni R. Statistical Methods for Analyzing Speedup Learning Experiments Machine Learning. 14: 333-347. DOI: 10.1023/A:1022617931401  0.32
1993 Ritchey ML, Kelalis PP, Etzioni R, Breslow N, Shochat S, Haase GM. Small bowel obstruction after nephrectomy for Wilms' tumor. A report of the National Wilms' Tumor Study-3. Annals of Surgery. 218: 654-9. PMID 8239780  0.32
1993 Etzioni R, Kadane JB. Optimal experimental design for another’s analysis Journal of the American Statistical Association. 88: 1404-1411. DOI: 10.1080/01621459.1993.10476425  0.32
1992 Ritchey ML, Kelalis PP, Breslow N, Etzioni R, Evans I, Haase GM, D'Angio GJ. Surgical complications after nephrectomy for Wilms' tumor. Surgery, Gynecology & Obstetrics. 175: 507-14. PMID 1333095  0.32
Show low-probability matches.